218 related articles for article (PubMed ID: 8102511)
1. Vitamin E treatment of tardive dyskinesia.
Adler LA; Peselow E; Rotrosen J; Duncan E; Lee M; Rosenthal M; Angrist B
Am J Psychiatry; 1993 Sep; 150(9):1405-7. PubMed ID: 8102511
[TBL] [Abstract][Full Text] [Related]
2. Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study.
Shriqui CL; Bradwejn J; Annable L; Jones BD
Am J Psychiatry; 1992 Mar; 149(3):391-3. PubMed ID: 1346951
[TBL] [Abstract][Full Text] [Related]
3. Treatment of tardive dyskinesia with vitamin E.
Egan MF; Hyde TM; Albers GW; Elkashef A; Alexander RC; Reeve A; Blum A; Saenz RE; Wyatt RJ
Am J Psychiatry; 1992 Jun; 149(6):773-7. PubMed ID: 1350428
[TBL] [Abstract][Full Text] [Related]
4. Vitamin E in the treatment of tardive dyskinesia.
Elkashef AM; Ruskin PE; Bacher N; Barrett D
Am J Psychiatry; 1990 Apr; 147(4):505-6. PubMed ID: 1969247
[TBL] [Abstract][Full Text] [Related]
5. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
Lohr JB; Caligiuri MP
J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552
[TBL] [Abstract][Full Text] [Related]
6. The effect of vitamin E treatment on tardive dyskinesia and blood superoxide dismutase: a double-blind placebo-controlled trial.
Zhang XY; Zhou DF; Cao LY; Xu CQ; Chen DC; Wu GY
J Clin Psychopharmacol; 2004 Feb; 24(1):83-6. PubMed ID: 14709952
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of vitamin E for treatment of long-term tardive dyskinesia.
Dabiri LM; Pasta D; Darby JK; Mosbacher D
Am J Psychiatry; 1994 Jun; 151(6):925-6. PubMed ID: 8185007
[TBL] [Abstract][Full Text] [Related]
8. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
Bai YM; Yu SC; Lin CC
J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
[TBL] [Abstract][Full Text] [Related]
9. Vitamin B(6) in the treatment of tardive dyskinesia: a double-blind, placebo-controlled, crossover study.
Lerner V; Miodownik C; Kaptsan A; Cohen H; Matar M; Loewenthal U; Kotler M
Am J Psychiatry; 2001 Sep; 158(9):1511-4. PubMed ID: 11532741
[TBL] [Abstract][Full Text] [Related]
10. Vitamin E treatment for tardive dyskinesia. Veterans Affairs Cooperative Study #394 Study Group.
Adler LA; Rotrosen J; Edson R; Lavori P; Lohr J; Hitzemann R; Raisch D; Caligiuri M; Tracy K
Arch Gen Psychiatry; 1999 Sep; 56(9):836-41. PubMed ID: 12892048
[TBL] [Abstract][Full Text] [Related]
11. Vitamin E in the treatment of tardive dyskinesia.
Akhtar S; Jajor TR; Kumar S
J Postgrad Med; 1993; 39(3):124-6. PubMed ID: 7914238
[TBL] [Abstract][Full Text] [Related]
12. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
Silver H; Geraisy N; Schwartz M
J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
[TBL] [Abstract][Full Text] [Related]
13. Vitamin E (alpha-tocopherol) in the treatment of tardive dyskinesia: a statistical meta-analysis.
Barak Y; Swartz M; Shamir E; Stein D; Weizman A
Ann Clin Psychiatry; 1998 Sep; 10(3):101-5. PubMed ID: 9781472
[TBL] [Abstract][Full Text] [Related]
14. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD
Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
[TBL] [Abstract][Full Text] [Related]
15. Vitamin E in tardive dyskinesia: time course of effect after placebo substitution.
Adler LA; Peselow E; Duncan E; Rosenthal M; Angrist B
Psychopharmacol Bull; 1993; 29(3):371-4. PubMed ID: 8121964
[TBL] [Abstract][Full Text] [Related]
16. Is melatonin treatment effective for tardive dyskinesia?
Shamir E; Barak Y; Plopsky I; Zisapel N; Elizur A; Weizman A
J Clin Psychiatry; 2000 Aug; 61(8):556-8. PubMed ID: 10982197
[TBL] [Abstract][Full Text] [Related]
17. Oxidative mechanisms and tardive dyskinesia.
Lohr JB; Kuczenski R; Niculescu AB
CNS Drugs; 2003; 17(1):47-62. PubMed ID: 12467492
[TBL] [Abstract][Full Text] [Related]
18. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
Lee JG; Shin BS; Lee YC; Park SW; Kim YH
Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029
[TBL] [Abstract][Full Text] [Related]
19. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810
[TBL] [Abstract][Full Text] [Related]
20. Changes in tardive dyskinesia symptoms in elderly patients treated with ganglioside GM1 or placebo.
Sommer BR; Cohen BM; Satlin A; Cole JO; Jandorf L; Dorsey F
J Geriatr Psychiatry Neurol; 1994; 7(4):234-7. PubMed ID: 7826493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
